Exact Mass: 340.1195

Diphacinone

C23H16O3 (340.1099)

B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AA - Vitamin k antagonists C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent

Oenanthoside A

C16H20O8 (340.1158)

Oenanthoside A is found in herbs and spices. Oenanthoside A is a constituent of Oenanthe javanica (water dropwort) Constituent of Oenanthe javanica (water dropwort). Oenanthoside A is found in herbs and spices.

Linocinnamarin

C16H20O8 (340.1158)

Linocinnamarin is found in coffee and coffee products. Linocinnamarin is a glycoside from seeds of Linum usitatissimum (flax

trans-isoeugenol-O-glucuronide

C16H20O8 (340.1158)

trans-isoeugenol-O-glucuronide is a conjugate of trans-isoeugenol and glucuronide. A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond. The glucuronides belong to the glycosides. Glucuronidation, the conversion of chemical compounds to glucuronides, is a method that animals use to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Enzymes that cleave the glycosidic bond of a glucuronide are called glucuronidases. (Wikipedia)

Macrosphelide B

C16H20O8 (340.1158)

COC1=CC(O)=C2C(=O)C3C(O)C(O)C(C)(O)CC3C(O)C2=C1O

C16H20O8 (340.1158)

Juglanoside C

C16H20O8 (340.1158)

Juglanoside B

C16H20O8 (340.1158)

Methyl 6-O-p-trans-coumaroyl-beta-D-glucopyranoside

C16H20O8 (340.1158)

MLS000862074

C19H20N2O2S (340.1245)

CP-863187

C18H14F2N4O (340.1136)

CONFIDENCE standard compound; INTERNAL_ID 478; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8284; ORIGINAL_PRECURSOR_SCAN_NO 8283 CONFIDENCE standard compound; INTERNAL_ID 478; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8325; ORIGINAL_PRECURSOR_SCAN_NO 8323 CONFIDENCE standard compound; INTERNAL_ID 478; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8328; ORIGINAL_PRECURSOR_SCAN_NO 8326 CONFIDENCE standard compound; INTERNAL_ID 478; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8370; ORIGINAL_PRECURSOR_SCAN_NO 8368 CONFIDENCE standard compound; INTERNAL_ID 478; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8368; ORIGINAL_PRECURSOR_SCAN_NO 8366 CONFIDENCE standard compound; INTERNAL_ID 478; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8380; ORIGINAL_PRECURSOR_SCAN_NO 8379

Pigment yellow 1

C17H16N4O4 (340.1171)

coniferaldehyde glucoside

C16H20O8 (340.1158)

4-(3-glucopyranosyloxy-4-hydroxyphenyl)-3-buten-2-one|4-(3-glucopyranosyloxy-4-hydroxyphenyl)-(E)-3-buten-2-one

C16H20O8 (340.1158)

3-O-methylallamancin

C16H20O8 (340.1158)

bisdethiodi(methylthio)hyalodendrin

C16H24N2O2S2 (340.1279)

6,7-dimethyl-1-ribitol-1-yl-1,4-dihydroquinoxaline-2,3-dione

C15H20N2O7 (340.127)

2-O-trans-isoferuloylrhamnopyranose

C16H20O8 (340.1158)

Me ester-Neoliacinic acid

C16H20O8 (340.1158)

ampelanol

C16H20O8 (340.1158)

2-O-trans-feruloyl-alpha-L-rhamnopyranose

C16H20O8 (340.1158)

3-O-transferuloyl-alpha-L-rhamnopyranose

C16H20O8 (340.1158)

2-methoxy-4-(2-carboxyvinyl)phenyl alpha-L-rhamnopyranoside

C16H20O8 (340.1158)

6-O-(4-methoxy-trans-cinnamoyl)-D-glucopyranose

C16H20O8 (340.1158)

3-O-trans-isoferuloylrhamnopyranose

C16H20O8 (340.1158)

CLATHRIDIMINE

C16H16N6O3 (340.1284)

2-beta-D-glucopyranosyloxy-trans-cinnamic acid methyl ester|2-beta-D-Glucopyranosyloxy-trans-zimtsaeure-methylester|Methyl o-coumarate-beta-D-glucoside

C16H20O8 (340.1158)

(2S*,2R*,3aR*,7aS*)-2,7a-dihydroxy-6,7,3a,7a-tetrahydrospiro[1,3-benzodioxole-2,1-cyclohex-3-ene]-2,3a-dicarboxylate|(?)-idesolide|idesolide

C16H20O8 (340.1158)

alpha-(o-Nitro-p-tolylazo)acetoacetanilide

C17H16N4O4 (340.1171)

http://casmi-contest.org/challenges-cat1-2.shtml; CASMI2012 LC Challenge 12

Coniferyl aldehyde + O-Hex

C16H20O8 (340.1158)

Annotation level-3

Leu-Thr-OH

C15H20N2O7 (340.127)

Ile-Thr-OH

C15H20N2O7 (340.127)

Thr-Val-OH

C15H20N2O7 (340.127)

Ser-Leu-OH

C15H20N2O7 (340.127)

Ser-Ile-OH

C15H20N2O7 (340.127)

LINOCINNAMARIN

C16H20O8 (340.1158)

Oenanthoside A

C16H20O8 (340.1158)

Chuanxiongoside A

C16H20O8 (340.1158)

Chlorosphaerolactylate A

C15H26O4Cl2 (340.1208)

(2S,1S)-2-CYCLOPROPYL-2-(1-PHENYLETHYLAMINO)ACETICACID

C15H20N2O7 (340.127)

Pigment Red 122

C22H16N2O2 (340.1212)

2,9-Dimethylquinacridone

C22H16N2O2 (340.1212)

4,4-diamino[1,1-bianthracene]-9,9,10,10-tetraone

C22H16N2O2 (340.1212)

Nilofabicin

C19H20N2O2S (340.1245)

C254 - Anti-Infective Agent > C258 - Antibiotic

4-(5-methoxy-3-phenyl-1,6-naphthyridin-2-yl)benzaldehyde

C22H16N2O2 (340.1212)

ETHYL 3-(SEC-BUTYLTHIO)-6,6-DIMETHYL-4-OXO-4,5,6,7-TETRAHYDROBENZO[C]THIOPHENE-1-CARBOXYLATE

C17H24O3S2 (340.1167)

N,N-Dimethylquinacridone

C22H16N2O2 (340.1212)

2-dos diazide triacetate

C12H16N6O6 (340.1131)

4-benzoyl-2,5-diphenyl-4H-pyrazol-3-one

C22H16N2O2 (340.1212)

4,5-BIS(PHENYLMETHOXY)-1,2-BENZENEDICARBONITRILE

C22H16N2O2 (340.1212)

ETHYL 2-(3-CHLORO-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOXY)ACETATE

C16H22BClO5 (340.1249)

3-(2-BIPHENYL-4-YL-IMIDAZO[1,2-A]PYRIDIN-3-YL)-ACRYLIC ACID

C22H16N2O2 (340.1212)

dinopenton

C15H20N2O7 (340.127)

1-Naphthalenecarboxaldehyde,2-hydroxy-, 2-[(2-hydroxy-1-naphthalenyl)methylene]hydrazone

C22H16N2O2 (340.1212)

nalpha-(2,4-dinitrophenyl)-l-arginine

C12H16N6O6 (340.1131)

3H-Thieno[2,3-d]imidazole-5-carboxylic acid,3-cyclohexyl-6-methyl-2-phenyl-

C19H20N2O2S (340.1245)

1-(4-BENZYLOXY-PHENYL)-PIPERAZINE DIHYDROCHLORIDE

C17H22Cl2N2O (340.1109)

TRIS(HYDROXYMETHYL)AMINOMETHANE PHOSPHATE,DIBASIC

C8H25N2O10P (340.1247)

I-XW-053

C22H16N2O2 (340.1212)

3-(2H-1,2,3-Triazol-4-yl)benzonitrile

C18H12N8 (340.1185)

4-PHENYL-1-(P-TOLYLSULPHONYL)PIPERIDINE-4-CARBONITRILE

C19H20N2O2S (340.1245)

Enarodustat

C17H16N4O4 (340.1171)

C78275 - Agent Affecting Blood or Body Fluid Enarodustat is a potent and orally active hypoxia-inducible factor prolyl hydroxylase inhibitor, with an EC50 of 0.22 μM. Enarodustat has the potential for renal anemia treatment.

BDP R6G carboxylic acid

C18H15BF2N2O2 (340.1195)

1,2,4-Triazolo(4,3-a)pyridine, 6-(4-(2,5-difluorophenyl)-5-oxazolyl)-3-(1-methylethyl)-

C18H14F2N4O (340.1136)

1-(N-Imidazolyl)-2-hydroxy-2-(2,3-dichlorophenyl)octane

C17H22Cl2N2O (340.1109)

Hansa yellow

C17H16N4O4 (340.1171)

N-butyl-N-phenyl-8-quinolinesulfonamide

C19H20N2O2S (340.1245)

7-Amino-5-(4-ethoxy-3-methoxyphenyl)-4-oxo-3,5-dihydropyrano[2,3-d]pyrimidine-6-carbonitrile

C17H16N4O4 (340.1171)

2,5-dimethyl-4-nitro-N-[4-(1-pyrazolylmethyl)phenyl]-3-pyrazolecarboxamide

C16H16N6O3 (340.1284)

N-[4-(1,3-benzothiazol-2-yl)phenyl]-N-methylcarbamic acid tert-butyl ester

C19H20N2O2S (340.1245)

2-fluoro-N-[2-(2-methylpropyl)-1,3-dioxo-5-isoindolyl]benzamide

C19H17FN2O3 (340.1223)

4-(4-Ethoxyphenyl)-1-(4-methoxyphenyl)-2-(methylthio)imidazole

C19H20N2O2S (340.1245)

N-[3,4-dihydro-2H-quinolin-1-yl(sulfanylidene)methyl]-2-(3-methylphenoxy)acetamide

C19H20N2O2S (340.1245)

6-(2-Benzyl-3-oxopropoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C16H20O8 (340.1158)

3,4,5-Trihydroxy-6-[(2-methyl-3-phenyloxiran-2-yl)methoxy]oxane-2-carboxylic acid

C16H20O8 (340.1158)

3,4,5-Trihydroxy-6-[1-(3-phenyloxiran-2-yl)ethoxy]oxane-2-carboxylic acid

C16H20O8 (340.1158)

(1-Acetyloxy-3-phosphonooxypropan-2-yl) octanoate

C13H25O8P (340.1287)

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) heptanoate

C13H25O8P (340.1287)

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) hexanoate

C13H25O8P (340.1287)

(2-Pentanoyloxy-3-phosphonooxypropyl) pentanoate

C13H25O8P (340.1287)

Diphacinone

C23H16O3 (340.1099)

B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AA - Vitamin k antagonists C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent

trans-isoeugenol-O-glucuronide

C16H20O8 (340.1158)

methyl (E)-3-[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-enoate

C16H20O8 (340.1158)

coniferaldehyde beta-D-glucoside

C16H20O8 (340.1158)

A beta-D-glucoside that is coniferaldehyde in which the phenolic hydrogen has been replaced by a beta-D-glucosyl residue.

Syk Inhibitor II

C14H15F3N6O (340.1259)

Syk Inhibitor II is a potent, high selective and ATP-competitive Syk inhibitor with an IC50 of 41 nM. Syk Inhibitor II inhibits 5-HT release from RBL-cells with an IC50 of 460 nM. Syk Inhibitor II shows less potent against other kinases and has anti-allergic effect[1].

2',7a-dimethyl 2',3a-dihydroxy-4,5-dihydrospiro[1,3-benzodioxole-2,1'-cyclohexan]-3'-ene-2',7a-dicarboxylate

C16H20O8 (340.1158)

2-ethoxy-5-hydroxy-6-methyl-4-oxooxan-3-yl 2,4-dihydroxy-6-methylbenzoate

C16H20O8 (340.1158)

methyl 3-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoate

C16H20O8 (340.1158)

6-hydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-naphthalen-1-one

C16H20O8 (340.1158)

methyl (2e)-3-{3-hydroxy-5-[(3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl}prop-2-enoate

C16H20O8 (340.1158)

3-(3-methoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enal

C16H20O8 (340.1158)

methyl (2e)-3-(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoate

C16H20O8 (340.1158)

(2s,3s,5r,6s)-2-ethoxy-5-hydroxy-6-methyl-4-oxooxan-3-yl 2,4-dihydroxy-6-methylbenzoate

C16H20O8 (340.1158)

1,2,3,4,8,10-hexahydroxy-6-methoxy-3-methyl-1,2,4,4a,9a,10-hexahydroanthracen-9-one

C16H20O8 (340.1158)

(4s,7e,9r,10s,13e,16s)-9-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12,15-tetrone

C16H20O8 (340.1158)

2',7a-dimethyl (2r,2's,3ar,7as)-2',3a-dihydroxy-4,5-dihydrospiro[1,3-benzodioxole-2,1'-cyclohexan]-3'-ene-2',7a-dicarboxylate

C16H20O8 (340.1158)

(1r,2s,3r,4s,4ar,9as,10s)-1,2,3,4,8,10-hexahydroxy-6-methoxy-3-methyl-1,2,4,4a,9a,10-hexahydroanthracen-9-one

C16H20O8 (340.1158)

(2s,3r,4r,5r,6s)-2,4,5-trihydroxy-6-methyloxan-3-yl (2e)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate

C16H20O8 (340.1158)

(4s)-6-hydroxy-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-naphthalen-1-one

C16H20O8 (340.1158)

methyl (2e)-3-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoate

C16H20O8 (340.1158)

4-(4-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)but-3-en-2-one

C16H20O8 (340.1158)

6-(2,4-dihydroxy-5-methoxy-3-methylphenoxy)-4,5-dihydroxy-3-methoxy-5-methylcyclohex-2-en-1-one

C16H20O8 (340.1158)

(1r,2r,3s,4as,9ar,10r)-1,2,3,4a,8,10-hexahydroxy-6-methoxy-3-methyl-2,4,9a,10-tetrahydro-1h-anthracen-9-one

C16H20O8 (340.1158)

[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C16H20O8 (340.1158)

6,7-dimethyl-1-(1,2,3,4,5-pentahydroxypentyl)-4h-quinoxaline-2,3-dione

C15H20N2O7 (340.127)

(1s,2r,3s,4as,9ar,10r)-1,2,3,5,8,10-hexahydroxy-6-methoxy-3-methyl-1,2,4,4a,9a,10-hexahydroanthracen-9-one

C16H20O8 (340.1158)

(2e)-3-(4-{[(2s,3s,4s,5r)-3,4-dihydroxy-5-[(1s)-1-hydroxyethyl]oxolan-2-yl]oxy}-3-hydroxyphenyl)-2-methylprop-2-enoic acid

C16H20O8 (340.1158)

(2s,3r,4r,5s,6s)-2,3,5-trihydroxy-6-methyloxan-4-yl (2e)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate

C16H20O8 (340.1158)

[(2r,3s,4s,5r,6r)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl (2e)-3-(4-methoxyphenyl)prop-2-enoate

C16H20O8 (340.1158)

(4r,5s,6r)-6-(2,4-dihydroxy-5-methoxy-3-methylphenoxy)-4,5-dihydroxy-3-methoxy-5-methylcyclohex-2-en-1-one

C16H20O8 (340.1158)

methyl 3-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoate

C16H20O8 (340.1158)

6,7-dimethyl-1-[(1s,2r,3r,4r)-1,2,3,4,5-pentahydroxypentyl]-4h-quinoxaline-2,3-dione

C15H20N2O7 (340.127)

(1r,2s,3r,4ar,9as,10s)-1,2,3,5,8,10-hexahydroxy-6-methoxy-3-methyl-1,2,4,4a,9a,10-hexahydroanthracen-9-one

C16H20O8 (340.1158)

1,2,3,5,8,10-hexahydroxy-6-methoxy-3-methyl-1,2,4,4a,9a,10-hexahydroanthracen-9-one

C16H20O8 (340.1158)

2,4,5-trihydroxy-6-methyloxan-3-yl 3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate

C16H20O8 (340.1158)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[6-(prop-2-en-1-yl)-2h-1,3-benzodioxol-4-yl]oxy}oxane-3,4,5-triol

C16H20O8 (340.1158)

(7e,13e)-9-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12,15-tetrone

C16H20O8 (340.1158)

(4s)-5-hydroxy-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-naphthalen-1-one

C16H20O8 (340.1158)

(3,4,5-trihydroxy-6-methoxyoxan-2-yl)methyl 3-(4-hydroxyphenyl)prop-2-enoate

C16H20O8 (340.1158)

(2e)-3-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enal

C16H20O8 (340.1158)

(3e)-4-(4-hydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)but-3-en-2-one

C16H20O8 (340.1158)

5-{[4-(2h-1,3-benzodioxol-5-ylmethyl)-1-methylimidazol-2-yl]imino}-2-imino-3-methylimidazolidin-4-one

C16H16N6O3 (340.1284)

(1s,2r,3s,4as,9ar,10s)-1,2,3,5,8,10-hexahydroxy-6-methoxy-3-methyl-1,2,4,4a,9a,10-hexahydroanthracen-9-one

C16H20O8 (340.1158)

(3,4,5,6-tetrahydroxyoxan-2-yl)methyl 3-(4-methoxyphenyl)prop-2-enoate

C16H20O8 (340.1158)

[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C16H20O8 (340.1158)

5-hydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-naphthalen-1-one

C16H20O8 (340.1158)

3-(4-{[3,4-dihydroxy-5-(1-hydroxyethyl)oxolan-2-yl]oxy}-3-hydroxyphenyl)-2-methylprop-2-enoic acid

C16H20O8 (340.1158)

2,3,5-trihydroxy-6-methyloxan-4-yl 3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate

C16H20O8 (340.1158)

2',7a-dimethyl (2s,2'r,3as,7ar)-2',3a-dihydroxy-4,5-dihydrospiro[1,3-benzodioxole-2,1'-cyclohexan]-3'-ene-2',7a-dicarboxylate

C16H20O8 (340.1158)

(1s,2r,3s,4r,4as,9ar,10r)-1,2,3,4,8,10-hexahydroxy-6-methoxy-3-methyl-1,2,4,4a,9a,10-hexahydroanthracen-9-one

C16H20O8 (340.1158)